Oculus Innovative Sciences

The MicrocynAH?family of animal healthcare products are the ONLY animal healthcare products formulated with the original Microcyn?Technology. With over ten million creatures successfully treated—both four-legged and two—there has never been a single report of a serious adverse effect as a result of being treated with Microcyn?based products. It is a superior hypochlorous acid solution that is clinically proven safe, non-toxic and effective. Can safely be used around the nose, eyes, ears and mouth and requires no mixing or dilution.

Oculus Innovative Sciences is a specialty pharmaceutical company traded on the NASDAQ (OCLS) since 2007. With its headquarters in Petaluma, California, Oculus?signature technology, the patented and proprietary Microcyn?platform, is now commercialized throughout the world in both advanced human and animal healthcare products.

Basic Information
Company Name:	Oculus Innovative Sciences
Business Type:	Manufacturer
Product/Services:	MicrocynAH products,
Brands:	MicrocynAH animal healthcare products
Number of Employees:	60 to 79
Company Website URL:	TradeNews.html
Ownership & Capital
Year Established:	1999
Legal Representative/CEO:	Jim Schutz
Legal Form:	Corporation/Limited Liability Company
Trade & Market
Main Markets:	Worldwide
Total Annual Sales Volume:	US$15,000,000 to 19,999,999